Evaluation of Gelatins for Cross-Linking Potential

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-01-2001
Volume 2001 Supplement
Issue 3

The authors describe a methodology to evaluate various gelatin raw materials with respect to their stability and resistance to cross&#173linking.

External Link - article-5135.pdf

Articles in this issue
A Novel Copovidone Binder for Dry Granulation and Direct-Compression Tableting
Effects of Natural and Pregelantinized Sorghum, Plantain, and Corn Starch Binders on the Compressional Characteristics of a Paracetamol Tablet Formulation
Formulation of Acetylsalicylic Acid Tablets for Aqueous Enteric Film Coating
Evaluation of Gelatins for Cross-Linking Potential
Fast-Melting Tablets: Developments and Technologies
Compendium of Pharmaceutical Excipients for Vaginal Formulations
Recent Videos
Drug Digest: Strategic Partnerships
Related Content
Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance

Susan J. Schniepp;Rona LeBlanc-Rivera, PhD
April 2nd 2025
Article

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Martin A. Makary Becomes New FDA Commissioner

Susan Haigney
April 2nd 2025
Article

Martin A. Makary, confirmed by a bipartisan vote of the US Senate, has been sworn in as FDA’s new commissioner.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

AES Clean Technology Introduces OSM Cleanroom Utility Solution at INTERPHEX 2025

Feliza Mirasol
April 1st 2025
Article

The Omni ASCENT, officially launched at INTERPHEX 2025, is a next-generation off-site manufactured vertical utility solution aimed at optimizing the flexibility and efficiency of cleanrooms.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Culture Biosciences Opens INTERPHEX 2025 with Launch of Cloud-Integrated Mobile Bioreactor

Patrick Lavery
April 1st 2025
Article

The company said the Stratyx 250 is the first bioreactor of its kind to offer biotech companies a combination of automation, remote process control, and flexibility.